Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (4786)	11/20/1997 12:39:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Managemen has changed. The deals with others were necessary to savehe co from e past disaster. A co must make choices. While I also have regrets when I see IDECs stock price or read ther annual report that is hindsight. They made difficult decisions and choose the BPI platform approach. They will earn more than pennies on the Genentech deal and it will go straight to the bottom line. When I read Connetics info I hope their T-Cell approach purchased from Xoma works but there are many others doing the same thing. Sometimes we ask XOMA do a deal now and at other times we correctly say don't give anything away. Very happy with the management team. They understand how to run a business and keep shareholders informed.While I made a point about Dr. Giroir his contribution was not discovering BPI but suggesting and convicing the co to use it for Meningococcemia. This is far different than what you have ust stated. Please see this as a sign of strength for XOMA. There are thousands of cos that would not have listened and done what they wanted. I see the relationship with the researchers as an incredible piece of good fortune and Xoma shares the limelight with them. Take a look at the 95 report. I don't see this bonding other repots from other cos. It is long term important to the success of XOMA IMO.

To: Pseudo Biologist who wrote (4786)	11/20/1997 1:19:00 PM
From: chirodoc	Read Replies (2) \| Respond to of 17367

<<<<<However, we do know the management of Xoma of the late 80's, early 90's (same as now?) was fairly incompetent and wasted a tremendous amount of sience and technology invented by their bright scientists. ........like you i am not only concerned with the technology of a company--a great management group that becomes profitable can buy the molecules or the research labs that it needs to go forward. .......i have a about 5K in this company but will not raise my ante until i hear that they have the management in place to make my money work for me. i am not in love with the michael murphy approach of buying the technology only while downplaying management expertise. ......do you think that arris was smart in buying sequana? to me it seems like a taste of things to come as these inhibited companies become swingers sleeping in each others beds ..........i think m and a activity will swell as products get closer to market and competition heats up (sorry for the double entendre). thus, at this point, management becomes a more important issue. .......i have been told that incyte and millenium have really good management--what do you think? who would you add to this? .......thank you for your insight in advance